Related Experiment Videos

A molecular approach to alopecia areata

R B Skinner¹, W H Light, C Leonardi

¹Department of Medicine (Dermatology and Internal Medicine), University of Tennessee College of Medicine, Memphis 38163, USA.

The Journal of Investigative Dermatology

|May 1, 1995

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Electrical Burn Injuries in the United States: Recent Demographic, Clinical, and Regional Patterns from the BCQP Registry.

Journal of burn care & research : official publication of the American Burn Association·2026

Abnormal Forgetting Rate from the Recency Portion of a Word-List in Patients with Subjective Cognitive Decline.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2025

Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

The British journal of dermatology·2021

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.

The British journal of dermatology·2020

Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).

The British journal of dermatology·2020

Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

See all related articles